CLINICAL RESEARCH OPPORTUNITIES IN INDIA: BEYOND THE FUTURE

Jeetu Gangil†*, Anish Kumar*, R.Rajesh*, Girish Thunga*, Sureshwar Pandey*

*Manipal College of Pharmaceutical Sciences, Manipal

Published By: Pharmabuzz. 2009; 8(4): 06-09

Abstract

India is emerging as a global hub for clinical research. According to projections from McKinsey & Company, the Indian clinical research industry could attract US $1.5 billion of revenue from U.S. and European sponsors by 2010, creating a demand for more than 10,000 investigators trained in good clinical practice (GCP) and supported by nearly 50,000 clinical research professionals. The revenue expected to be reaching US $ 20 billion in India till 2015.With increased outsourcing from the U.S. and Europe to India, global pharmaceutical companies and Indian entrepreneurs have set up contract research organizations (CROs) in India. They are attracting highly competent professionals, both in the clinical research profession and the knowledge process outsourcing sector.

Available at: http://www.pharmabuzz.org/cover_article.php?feature_id=42

The OPPI: A Soldier of Indian Pharma Marketing and Research

Jeetu Gangil, Girish Thunga

Manipal College of Pharmaceutical Sciences, Manipal

Published By: The Pharma Review. 2010; 42-46

Abstract

The Organization of Pharmaceutical Producers of India (The OPPI) is a leading organization of pharmaceutical manufactures in India. Mission of this organization is to serve the collective interests of the members professionally so as to make sure a healthy environment for commercial growth of pharmaceutical market. The OPPI is actively engaged in designing and conducting training programmes for managers working in the Pharmaceutical Industry to furnish them for competing in the global setting. The OPPI Maintain that Promotional information should be clear, legible, accurate, balanced, fair, objective and sufficiently complete to enable the recipient to form his or her own opinion of the therapeutic value of the pharmaceutical product concerned.

Keywords: Indian Pharmaceutical Market, IFPMA, OPPI

Available at: http://www.kppub.com/articles/jan2010/the_OPPI_a_soldier_of_indian_pharma_marketing_and_research.html  

Prescription Drug Labeling Medication Errors: A Big Deal for Pharmacists

Gangil Jeetu, Thunga Girish

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India


Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035877/

Abstract

Today, in the health care profession, all types of medication errors including missed dose, wrong dosage forms, wrong time interval, wrong route, etc., are a big deal for better patient care. Today, problems related to medications are common in the healthcare profession, and are responsible for significant morbidity, mortality, and cost. Several recent studies have demonstrated that patients frequently have difficulty in reading and understanding medication labels. According to the Institute of Medicine report, “Preventing Medication Errors,” cited poor labeling as a central cause for medication errors in the USA. Evidence suggests that specific content and format of prescription drug labels facilitate communication with and comprehension by patients. Efforts to improve the labels should be guided by such evidence, although an additional study assessing the influence of label design on medication-taking behavior and health outcomes is needed. Several policy options exist to require minimal standards to optimize medical therapy, particularly in light of the new Medicare prescription drug benefit.

Keywords: Health care profession ,Labeling ,Medication error